The Affiliated Hospital Of Xuzhou Medical University

This study tests a new treatment using donor immune cells (CAR T-cells) that are engineered to target and destroy faulty immune cells in people with severe lupus or scleroderma. The goal is to control the disease by resetting the immune system. The trial involves 18 adults whose …